BACKGROUND: Prior studies show that lactate is a useful prognostic marker in sepsis. OBJECTIVE: To study the feasibility and accuracy of a point-of-care (POC) analyzer capable of performing bedside serum lactate measurements; and to determine if other measurements (pH, base excess) are predictive of mortality. DESIGN: prospective cohort study of adult (age 18 years or older) Emergency Department (ED) patients with suspected infection during the study period of May 2006 through March 2007. SETTING: A 55,000-annual-visit urban tertiary care ED. INTERVENTION: A point-of-care device (i-STAT, Abbott Point of Care Inc., Princeton, NJ) was deployed using a standardized training and quality assurance process. Using POC testing, we measured serum lactate, pH, and base excess, as well as concomitant lactate measurement via a central laboratory. STATISTICS: Area under the curve (AUC) for receiver operator characteristic curve, Bland-Altman statistics along with a correlation coefficient, and relative risk with 95% confidence intervals reported. RESULTS: There were 699 patients enrolled, of whom 34 (4.9%) died. The AUCs for mortality prediction were: POC lactate 0.72, laboratory lactate 0.70, pH measurement 0.60, and base excess 0.60. Bland-Altman showed that POC lactate was, on average, 0.32 (95% confidence interval -0.35-0.98) lower than laboratory lactate, with agreement kappa = 0.97. CONCLUSIONS: A point-of-care testing device provides a reliable and feasible way to measure serum lactate at the bedside. The pH and base excess were less helpful. Copyright 2010 Elsevier Inc. All rights reserved.
BACKGROUND: Prior studies show that lactate is a useful prognostic marker in sepsis. OBJECTIVE: To study the feasibility and accuracy of a point-of-care (POC) analyzer capable of performing bedside serum lactate measurements; and to determine if other measurements (pH, base excess) are predictive of mortality. DESIGN: prospective cohort study of adult (age 18 years or older) Emergency Department (ED) patients with suspected infection during the study period of May 2006 through March 2007. SETTING: A 55,000-annual-visit urban tertiary care ED. INTERVENTION: A point-of-care device (i-STAT, Abbott Point of Care Inc., Princeton, NJ) was deployed using a standardized training and quality assurance process. Using POC testing, we measured serum lactate, pH, and base excess, as well as concomitant lactate measurement via a central laboratory. STATISTICS: Area under the curve (AUC) for receiver operator characteristic curve, Bland-Altman statistics along with a correlation coefficient, and relative risk with 95% confidence intervals reported. RESULTS: There were 699 patients enrolled, of whom 34 (4.9%) died. The AUCs for mortality prediction were: POC lactate 0.72, laboratory lactate 0.70, pH measurement 0.60, and base excess 0.60. Bland-Altman showed that POC lactate was, on average, 0.32 (95% confidence interval -0.35-0.98) lower than laboratory lactate, with agreement kappa = 0.97. CONCLUSIONS: A point-of-care testing device provides a reliable and feasible way to measure serum lactate at the bedside. The pH and base excess were less helpful. Copyright 2010 Elsevier Inc. All rights reserved.
Authors: E Rivers; B Nguyen; S Havstad; J Ressler; A Muzzin; B Knoblich; E Peterson; M Tomlanovich Journal: N Engl J Med Date: 2001-11-08 Impact factor: 91.245
Authors: Nathan Shapiro; Michael D Howell; David W Bates; Derek C Angus; Long Ngo; Daniel Talmor Journal: Ann Emerg Med Date: 2006-11 Impact factor: 5.721
Authors: Stephen Trzeciak; R Phillip Dellinger; Michael E Chansky; Ryan C Arnold; Christa Schorr; Barry Milcarek; Steven M Hollenberg; Joseph E Parrillo Journal: Intensive Care Med Date: 2007-03-13 Impact factor: 17.440
Authors: Nathan I Shapiro; Michael D Howell; Daniel Talmor; Larry A Nathanson; Alan Lisbon; Richard E Wolfe; J Woodrow Weiss Journal: Ann Emerg Med Date: 2005-05 Impact factor: 5.721
Authors: R Phillip Dellinger; Mitchell M Levy; Jean M Carlet; Julian Bion; Margaret M Parker; Roman Jaeschke; Konrad Reinhart; Derek C Angus; Christian Brun-Buisson; Richard Beale; Thierry Calandra; Jean-Francois Dhainaut; Herwig Gerlach; Maurene Harvey; John J Marini; John Marshall; Marco Ranieri; Graham Ramsay; Jonathan Sevransky; B Taylor Thompson; Sean Townsend; Jeffrey S Vender; Janice L Zimmerman; Jean-Louis Vincent Journal: Crit Care Med Date: 2008-01 Impact factor: 7.598
Authors: Nathan I Shapiro; Michael D Howell; Daniel Talmor; Dermot Lahey; Long Ngo; Jon Buras; Richard E Wolfe; J Woodrow Weiss; Alan Lisbon Journal: Crit Care Med Date: 2006-04 Impact factor: 7.598
Authors: R Phillip Dellinger; Jean M Carlet; Henry Masur; Herwig Gerlach; Thierry Calandra; Jonathan Cohen; Juan Gea-Banacloche; Didier Keh; John C Marshall; Margaret M Parker; Graham Ramsay; Janice L Zimmerman; Jean-Louis Vincent; Mitchell M Levy Journal: Crit Care Med Date: 2004-03 Impact factor: 7.598
Authors: Michael D Howell; Michael Donnino; Peter Clardy; Daniel Talmor; Nathan I Shapiro Journal: Intensive Care Med Date: 2007-07-06 Impact factor: 17.440
Authors: Philipp Schuetz; Alan E Jones; Michael D Howell; Stephen Trzeciak; Long Ngo; John G Younger; William Aird; Nathan I Shapiro Journal: Ann Emerg Med Date: 2011-06-16 Impact factor: 5.721
Authors: Adam Froehlich; Ryan J Tegtmeier; Brett A Faine; Jennifer Reece; Azeemuddin Ahmed; Nicholas M Mohr Journal: J Crit Care Date: 2019-04-19 Impact factor: 3.425
Authors: Alan E Jones; Nathan I Shapiro; Stephen Trzeciak; Ryan C Arnold; Heather A Claremont; Jeffrey A Kline Journal: JAMA Date: 2010-02-24 Impact factor: 56.272
Authors: Elizabeth Morris; David McCartney; Daniel Lasserson; Ann Van den Bruel; Rebecca Fisher; Gail Hayward Journal: Br J Gen Pract Date: 2017-11-20 Impact factor: 5.386
Authors: Nathan I Shapiro; Philipp Schuetz; Kiichiro Yano; Midori Sorasaki; Samir M Parikh; Alan E Jones; Stephen Trzeciak; Long Ngo; William C Aird Journal: Crit Care Date: 2010-10-13 Impact factor: 9.097